76x cash transfers: too good to be true or a (missed) opportunity? An invitation for dialogue on a recent Rethink Priorities Report

Published on October 7, 2026 10:45 AM GMT  TL;DR GOAL 3 is a social enterprise that created IMPALA, a patient monitoring and digital platform system for low-resource settings. There is also a GOAL 3 foundation that raises funds to ensure underserved communities will be reached. A recently completed report from Rethink Priorities calculated IMPALA to have a cost per DALY averted of $7–17 in paediatric care and $12–30 in neonatal care. This translates to around 76× and 28× unconditional cash transfers respectively for paediatrics and neonates against GiveWell's bar, and roughly 11,700× and 4,400× on Coefficient Giving's scale against their 1,000× bar. RP corrected for study design and robustness of findings by applying a 60% internal-validity and a 30% external-validity discount to our measured mortality effects, arriving at roughly 12% for paediatric wards and 7% for neonatal units. RP concluded that even at 1-2% relative reduction, the intervention would still be cost-effective. The post concludes with an invitation for discussion on what these results mean for further research and scaling of IMPALA. Introduction GOAL 3 commissioned the Rethink Priorities Global Health and Development team to provide an external analysis of the impact and cost-effectiveness of our product ‘IMPALA.’ IMPALA is a continuous patient monitor combined with a digital health platform designed for low-resource settings (links with more info in the appendix). The report estimates that IMPALA is highly cost-effective, far surpassing every funding threshold considered. We would like to use this post to discuss the studied intervention, the results, the questions that may arise as a result, and how we can address these now or in the future.  Understanding the problem in its context Sub-Saharan Africa accounted for 2.8 million of the 4.9 million deaths of children under five worldwide in 2024.[1] Access to care alone does not prevent these deaths. In low- and middle-income countries, an estimated 58% of all amenable deaths from conditions treatable by health care occur among people who did use the health system but received sub standard-quality care.[2] Important root causes to this challenge are lack of adequate equipment and shortage of staff. In many low-and-middle-income countries (LMICs) there is a huge shortage of staff. WHO uses 4.45 doctors, nurses and midwives per 1,000 people as an indicative minimum for progress on the health-related Sustainable Development Goals.[3] A survey of 47 countries found that the WHO African Region had an average of 1.5 doctors, nurses and midwives per 1,000 people, about a third of WHO's minimum (Malawi was even below 0.5, less than a ninth).[4] Moreover, staff lack the equipment they need to monitor and manage their patients with up to 40% of equipment malfunctioning. Qualitative studies in paediatric high-dependency units in Malawi describe monitoring as intermittent, with nurses forced to focus on the sickest children while staff shortages, power cuts and too few working devices get in the way. [5] In these conditions, health workers are often unable to recognize and act upon patient deterioration, forcing them into reactive care; leading to late stage response to emergencies when treatments are more costly and more time consuming while outcomes are poor. This sets off a vicious cycle whereby scarce time and resources are used on late-stage escape treatments, further hampering the ability of the health systems to respond in time to changing patient conditions. Theory of Change IMPALA enables health workers to monitor patients continuous with health workers receiving alerts when a patient deteriorates. As a result, health workers can recognise patient deterioration earlier and prioritise care more effectively. Monitoring also reduces staff workload. By automating the process of checking vital signs, IMPALA helps save hours of work for health workers every shift[6], allowing them to focus their attention where it is most needed.  Additionally, when patients are treated earlier, complications can be prevented and treatment demands fewer resources. This means less medicine use, less patient costs, and reduced time spent on treating the child by the health workers. The result is reduced health expenditure. [7] Importantly, IMPALA is not an intervention that increases the burden on already overworked health workers but is embedded into their existing workflows and makes this easier. Each implementation includes on-site training for the ward team, a group of trained IMPALA champions among the hospital's own staff who support colleagues and onboard new starters, and ongoing follow-up from our in-country team through IMPALA Care.  Figure 1: GOAL 3 Theory of Change of IMPALA What the RP report tells us Rethink Priorities' Global Health and Development team took on the challenge of evaluating our evidence, commissioned by GOAL 3. RP reviewed nine mortality estimates from hospitals in Malawi, Rwanda and